[{"address1": "8000 Innovation Parkway", "city": "Baton Rouge", "state": "LA", "zip": "70820", "country": "United States", "phone": "919 518 3748", "website": "https://adherathera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andrew Albert Kucharchuk M.B.A.", "age": 42, "title": "Vice Chairman, COO, Acting CFO & Chief Business Officer", "yearBorn": 1981, "fiscalYear": 2022, "totalPay": 285000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.016, "open": 0.018, "dayLow": 0.015, "dayHigh": 0.018, "regularMarketPreviousClose": 0.016, "regularMarketOpen": 0.018, "regularMarketDayLow": 0.015, "regularMarketDayHigh": 0.018, "beta": 0.081, "volume": 364652, "regularMarketVolume": 364652, "averageVolume": 236973, "averageVolume10days": 74630, "averageDailyVolume10Day": 74630, "marketCap": 108313, "fiftyTwoWeekLow": 0.01, "fiftyTwoWeekHigh": 0.95, "fiftyDayAverage": 0.0208, "twoHundredDayAverage": 0.07425, "currency": "USD", "enterpriseValue": 10905048, "floatShares": 6556000, "sharesOutstanding": 7220900, "sharesShort": 2046, "sharesShortPriorMonth": 1986, "sharesShortPreviousMonthDate": 1322611200, "dateShortInterest": 1327968000, "sharesPercentSharesOut": 0.0392, "heldPercentInsiders": 0.11667, "shortRatio": 3.24, "shortPercentOfFloat": 0.039300002, "impliedSharesOutstanding": 7220930, "bookValue": -5.091, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -4610754, "trailingEps": -1.17, "lastSplitFactor": "1:20", "lastSplitDate": 1665014400, "52WeekChange": -0.9714286, "SandP52WeekChange": 0.21733451, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "ATRX", "underlyingSymbol": "ATRX", "shortName": "ADHERA THERAPEUTICS INC", "longName": "Adhera Therapeutics, Inc.", "firstTradeDateEpochUtc": 755274600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "89731d22-9c3b-38a9-b5e4-eb9859bed2d2", "messageBoardId": "finmb_280596151", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.015, "recommendationKey": "none", "totalCash": 32388, "totalCashPerShare": 0.004, "totalDebt": 10829120, "quickRatio": 0.001, "currentRatio": 0.002, "returnOnAssets": -5.3288097, "freeCashflow": 563753, "operatingCashflow": -714193, "financialCurrency": "USD", "trailingPegRatio": null}]